Divi`s Laboratories surges on reporting 17% rise in Q3 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Divi's Laboratories is currently trading at Rs. 3751.95, up by 100.95 points or 2.76% from its previous closing of Rs. 3651.00 on the BSE.
The scrip opened at Rs. 3650.00 and has touched a high and low of Rs. 3822.70 and Rs. 3648.70 respectively. So far 25265 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 4072.35 on 04-Jan-2024 and a 52 week low of Rs. 2730.00 on 14-Mar-2023.
Last one week high and low of the scrip stood at Rs. 3822.70 and Rs. 3616.85 respectively. The current market cap of the company is Rs. 99602.48 crore.
The promoters holding in the company stood at 51.92%, while Institutions and Non-Institutions held 36.74% and 11.34% respectively.
Divi's Laboratories has reported results for third quarter ended December 31, 2023 (Q3FY24).
The company has reported 15.48% rise in its net profit at Rs 358 crore for the third quarter ended December 31, 2023 as compared to Rs 310 crore for the same quarter in the previous year. Total income of the company increased by 5.26% at Rs 1902 crore for Q3FY24 as compared Rs 1807 crore for corresponding quarter of the previous year.
On consolidated basis, the company has reported 16.99% rise in net profit at Rs 358 crore for Q3FY24 as compared to Rs 306 crore for the same quarter in the previous year. Total income of the company increased by 7.08% at Rs 1950 crore for Q3FY24 as compared Rs 1821 crore for corresponding quarter of the previous year.
